Back

Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Management of comorbidities and outcomes in atrial fibrillation (1) Atrial Stressors ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Natalia Atzemian

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

7 More presentations in this session

Presentation thumbnail
Semaglutide and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials
Doctor G. Costa (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Inflammation and long-term outcomes after first-time direct current cardioversion for atrial fibrillation: a nationwide register study
Doctor A. Langhoff (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial aibrillation: a report from 2 prospective observational registries
Doctor J. Imberti (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Risk of embolic events in patients with Chagasic Cardiomyopathy and Atrial Fibrillation despite antithrombotic therapy: is anticoagulation enough?
Doctor L. Echeverria (Floridablanca, CO)
Abstract Slides
Presentation thumbnail
Treated obstructive sleep apnoea and incident arrhythmias
Doctor H. He (Coventry, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Management of comorbidities and outcomes in atrial fibrillation (1)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Proteomic biomarkers and biological mechanisms associated with atrial fibrillation in heart failure patients
thumbnail
Congress Presentation
Proteinuria and the risk of incident atrial fibrillation according to diabetes stage in patients with diabetes: a nationwide population-based cohort study
thumbnail
Congress Presentation
Impact of changes in proteinuria on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources